Abstract
Background: The primary objective of the global DISCOVER study (NCT02322762) is to describe disease management patterns and clinical evolution over three years in type 2 diabetes mellitus (T2DM). We report the baseline characteristics of the Canadian cohort enrolled in DISCOVER.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have